Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Olba Healthcare Holdings (TSE:2689) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Olba Healthcare Holdings Net Margin % Related Terms
Olba Healthcare Holdings Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:2689 vs MCK, COR, CAH: Net Margin % Comparison
For the Medical Distribution subindustry, Olba Healthcare Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Olba Healthcare Holdings Net Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Olba Healthcare Holdings's Net Margin % distribution charts can be found below:
* The bar in red indicates where Olba Healthcare Holdings's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Olba Healthcare Holdings (TSE:2689) has a Net Margin % of 0.00% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Olba Healthcare Holdings and its competitors. Over the past decade, Olba Healthcare Holdings' Net Margin % has ranged from 0.30 to 1.42. According to the industry distribution chart, Olba Healthcare Holdings ranks #74 out of 118 companies in the Medical Distribution industry, placing it in the top 62.7%.
Is Olba Healthcare Holdings' Net Margin % too high?
Olba Healthcare Holdings' current Net Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 0.30 to a high of 1.42. Based on the distribution chart, Olba Healthcare Holdings ranks #74 out of 118 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Olba Healthcare Holdings has a GF Score™ of 63/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Olba Healthcare Holdings' Net Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Olba Healthcare Holdings ranks #74 out of 118 companies for Net Margin %. This places Olba Healthcare Holdings in the lower half of its industry. The industry median Net Margin % is 1.43. Historically, Olba Healthcare Holdings' own Net Margin % has ranged from 0.30 to 1.42 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Distribution company?
The median Net Margin % among Medical Distribution companies is 1.43, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Olba Healthcare Holdings and its competitors. For the Medical Distribution industry, the median Net Margin % is 1.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Olba Healthcare Holdings's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olba Healthcare Holdings stock overvalued right now?
Based on GuruFocus' analysis, Olba Healthcare Holdings (TSE:2689) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,619.26, compared to a current price of 円1,901.00 — trading 17.4% above its estimated fair value. The current Net Margin % is 0.00%. Olba Healthcare Holdings' overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Olba Healthcare Holdings (TSE:2689), the current Net Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Olba Healthcare Holdings (TSE:2689) Overvalued in 2026?
Based on GuruFocus' analysis, Olba Healthcare Holdings stock appears to be overvalued.
The current stock price of 円1,901.00 is trading 17.4% above its estimated GF Value™ of 円1,619.26.
GuruFocus considers Olba Healthcare Holdings to be Modestly Overvalued.
Key valuation signals for TSE:2689:
Net Margin %: 0.00%
GF Value™: 円1,619.26 vs. price of 円1,901.00 (17.4% above fair value)
No single metric tells the full story. See the TSE:2689 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Olba Healthcare Holdings Inc is a Japan-based holding company that engages in the wholesale distribution of medical diagnostic equipment and medical materials. It operates through the following business divisions: Medical Equipment, Supply, Processing, and Distribution (SPD), and Nursing Care Products.
63GF Score
Get the complete analysis for TSE:2689
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2689 has been successfully added to your 
